Paxquill
A multi-language FHIR client, payer sandbox harness, and managed clinical UI for building reviewable drug prior-authorization workflows against the emerging CMS stack.
Drug prior authorization remains dominated by enterprise portals and closed integrations while a new CMS proposal points toward a defined FHIR stack and a 2027 compliance window. Clinical software teams can read the implementation guides, but still have to solve payer discovery, sandbox behavior, conformance testing, retries, and review evidence on their own. The opening is a developer-first substrate that makes those differences testable without claiming that a successful API exchange guarantees coverage or regulatory compliance.
The engineering or interoperability leader at a clinical software company, specialty practice platform, or provider group that needs to add drug prior authorization without negotiating a closed enterprise integration first.
The April 2026 proposal and stated 2027 window create a current planning trigger.
Clients, simulators, and conformance fixtures scale primarily through code.
The record has several inbound connections but limited independent convergence.
A confirmed federal proposal, active implementation guides, and a clear developer buyer create a timely infrastructure wedge with strong code leverage.
The rule is proposed, four cited capabilities remain unverified, payer variance is substantial, and closed incumbents can expose better developer surfaces.
Discussion
No comments yet — be the first to weigh in.